Blockchain Registration Transaction Record

Heart Association Launches Initiative to Speed Aortic Stenosis Diagnosis & Treatment

American Heart Association launches initiative with Kardigan to boost aortic stenosis clinical trial participation & early diagnosis through 40+ hospitals. Learn about new treatment access.

This initiative addresses a critical gap in cardiovascular care where aortic stenosis often goes undiagnosed until advanced stages, leading to preventable complications and deaths. For patients and families, earlier detection through expanded clinical trial access could mean life-saving interventions before irreversible damage occurs. The program's focus on moderate AS cases represents a proactive approach that could shift treatment paradigms from reactive to preventive care. By connecting thousands of patients with emerging therapies and advancing research participation, this effort has the potential to accelerate medical breakthroughs that benefit the estimated millions affected by heart valve diseases worldwide. The collaboration between leading medical organizations and innovative companies like Kardigan demonstrates how strategic partnerships can drive meaningful progress in tackling complex cardiovascular conditions that impact quality of life and survival rates.